Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gastric Condition Assessment Pivotal Study
jRCT1070260016Not yet recruiting
- Sponsor
- Sawai Pharmaceutical
- Start
- May 2026
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of acetaminophen, rabeprazole and ropivacaine, sponsored by Sawai Pharmaceutical. Primary endpoints: Gastric emptying rate, Gastric content evaluation and 1 more. Planned start May 2026; status: not yet recruiting.
02
Drugs
acetaminophenrabeprazoleropivacaine
Beyond the preview
Go deeper on jRCT1070260016.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1070260016.